Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2005
08/10/2005EP1560576A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins
08/10/2005EP1560573A2 Therapeutic agents and corresponding treatments
08/10/2005EP1507514A4 Controlled release compositions of estradiol metabolites
08/10/2005EP1461457A4 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
08/10/2005EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1395599B1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives
08/10/2005EP1377588B1 4-beta-1''-[(2''-(substituted benzoyl)anilino] podophyllotoxin analogues useful as anticancer agents
08/10/2005EP1358187B1 Naphthyridine derivatives
08/10/2005EP1358168B1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1343826B1 Polysaccharide compound having immune stimulating activity
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis
08/10/2005EP1051189B1 Vaccine formulation comprising sugar-alcohols and low concentrations of anorganic ions
08/10/2005EP1009447B1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
08/10/2005EP0888301B1 Mcbi analogs of cc-1065 and the duocarmycins
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
08/10/2005CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
08/10/2005CN1653182A Recombinant fowlpox virus
08/10/2005CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof
08/10/2005CN1653082A Platinum complexes having antitumor activity
08/10/2005CN1653080A Lymphatic and blood endothelial cell genes
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1652845A Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
08/10/2005CN1652844A Combination of a CDK inhibitor and 5-FU for the treatment of cancer
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652818A Fuel additive
08/10/2005CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic
08/10/2005CN1652800A Remedies for lung cancer
08/10/2005CN1652792A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652790A Novel crystalline forms of the anti-cancer compound ZD1839
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652780A Diaminothiazoles used as CDK4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652773A Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652765A Antitumor agent containing cyclic polylactic acid
08/10/2005CN1652764A TGF-alpha expression inhibitors
08/10/2005CN1652757A Use of EDG receptor binding agents in cancer
08/10/2005CN1652698A Method and dietary composition for improving lipid digestibility
08/10/2005CN1652697A Method and dietary composition for improving fat digestibility
08/10/2005CN1652696A Method of improving absorption of vitamin E by a pet animal
08/10/2005CN1651577A Conditionally replicating viral vectors and their use
08/10/2005CN1651561A Dry red persimmon wine and its brewing method
08/10/2005CN1651466A Sulphatization derivative of polysaccharide, its preparation method and use
08/10/2005CN1651461A Polyethylene glycol modified and recombined human interleukin and its preparation method
08/10/2005CN1651455A Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine
08/10/2005CN1651452A Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient
08/10/2005CN1651451A 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application
08/10/2005CN1651450A Small interference RNA molecule (SiRNA) capable of effectively killing and wounding tumour cell pointed at PLK1 mRNA, its mixture and use
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1651420A Dehydro methyl abietate furazan derivative, its synthesis method and use
08/10/2005CN1651418A Human epidermis growth factor acceptor 2 tyrosinase inhibitor
08/10/2005CN1651362A One and two step ultracritical fluid extraction of carotene, VE and other trace element concentration
08/10/2005CN1651078A Medicinal composition for anti tumour and antisenility
08/10/2005CN1651076A Method of extracting rainbow conk saccharide peptide for injection in rainbow conk saccharided peptide crude product obtained from submerged fermentation
08/10/2005CN1651064A Medicinal composition for treating tumour and its preparation method
08/10/2005CN1651058A Chinese medicine for treating tumour
08/10/2005CN1651041A Brazil mushroom soluble small molecular extract, its preparation technology and use
08/10/2005CN1651035A Medicine for treating leucocythemia and its preparation method
08/10/2005CN1651005A Chinese medicinal composition containing corrigent and its preparation method
08/10/2005CN1651002A Chinese medicinal composition, its preparation method and application
08/10/2005CN1650996A Medicinal composition, its preparation method and application
08/10/2005CN1650991A Traditional Chinese medicine for treating tumour and its preparation method
08/10/2005CN1650974A Life prolonging tumour inhibiting cancer treating Chinese medicine oral liquid and its preparation method
08/10/2005CN1650946A Medicine for treating lung cancer and its preparation method
08/10/2005CN1650939A Health care tea for preventing cancer, lowering blood fat and lowering blood pressure
08/10/2005CN1650908A Method of extracting total flavone product from halenalin plant full flower
08/10/2005CN1650883A Jixitabing hydrochloride solution type injection agent
08/10/2005CN1650880A Antilung gland cancer medicine, its preparation method and its application
08/10/2005CN1650869A Medicine using shell sepal saponin as active component and its application in medicament
08/10/2005CN1650865A 10-hydoxy camptothecin self micro emulsifieation composition
08/10/2005CN1650864A 10-hydroxy camptothecin long cyclic liposome and its freeze aried preparation
08/10/2005CN1650856A Sensitizing energistic agent of chemotherapy medicine for treating tumour
08/10/2005CN1650855A Rabdosia rubescens injection agent and its preparation technology
08/10/2005CN1650853A Doxy rhodol magnetic microglobule and its making method
08/10/2005CN1650846A Elemene liposome and its preparation method
08/10/2005CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
08/10/2005CN1214044C ErdB3 antibodies
08/10/2005CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213998C Processes and intermediates useful to make antifolates
08/10/2005CN1213980C Vitamin D analogues
1 ... 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 ... 2211